Navigation Links
Neuromonics Signs Reselling Agreement with Elite Hearing Network
Date:8/13/2014

Westminster, CO (PRWEB) August 13, 2014

Neuromonics, Inc., manufacturer and distributor of clinically proven tinnitus treatment devices, has signed a new reseller agreement with Elite Hearing Network.

Elite will offer special pricing, marketing, training and other support for all Neuromonics products to its network of 800 clinicians through the agreement. Elite provides business support services to independent hearing care practices throughout the United States. The agreement extends a relationship Neuromonics has had with Elite since 2012, according to Eula Adams, CEO of Neuromonics.

“The new agreement further builds on a strong relationship between Elite and Neuromonics,” says Adams. “Elite Hearing is a critical link to Neuromonics’ ability to deliver the miracle of tinnitus relief to tinnitus sufferers.”

Neuromonics manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus, the condition often described as buzzing, ringing, hissing, humming, roaring, whistling or "ringing in the ears” that someone hears in the absence of any external sound. Globally, tinnitus affects an estimated 10-15 percent of the population. In the United States alone, more than 50 million people suffer from the condition, according to the American Tinnitus Association. Usually brought on by exposure to loud noise, tinnitus is especially significant in the military, with more than 34 percent of returning veterans from Iraq and Afghanistan suffering from the condition.

Neuromonics products use calming, relaxing music embedded with a neural stimulus that interacts with the tinnitus perception, explains Adams. The music engages the auditory pathways to promote neural plastic changes. Over time, these changes help the brain to filter out the tinnitus perception, reducing tinnitus disturbance and providing long-term relief from symptoms. The compact devices are simple to use, function much like familiar consumer music players, and fit easily into patients’ lifestyles.

Neuromonics, Inc. (http://www.neuromonics.com)
Based in Westminster, Colo., Neuromonics, Inc., manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus. The patented and clinically proven Oasis, working the Neuromonics Tinnitus Treatment, provides long-term treatment and significant relief for those with severe tinnitus. The Haven, with the ability to program and individualize hearing profiles, is a management tool offering situational relief for tinnitus symptoms. The Sanctuary, also a management tool, works with pre-programmed profiles for on-demand relief.

With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. More than 400 licensed, trained audiologists across four continents administer the Neuromonics Tinnitus Treatment. Neuromonics news includes segments on national media including “The Doctors” and CNN.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12087827.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Neuromonics Names Eula Adams CEO
2. Neuromonics Unveils New Device to Relieve Mild, Moderate Tinnitus at Audiology NOW!
3. Know the Risks and Warning Signs of Brain Aneurysms--What You Need to Know Right Now is Available Through the Brain Aneurysm Foundation
4. 5 Signs That Insulation Should Be Replaced Detailed in a Newly Released Article By Clean Crawls
5. Rewired mice show signs of longer lives with fewer age-related illnesses
6. Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout
7. Healthy Habits May Slow Cellular Signs of Aging, Study Finds
8. New radiological signs of gastric lap band slippage identified
9. Research led by Temples chair of dermatology: Pain and itch may be signs of skin cancer
10. Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow
11. New Designs of Sweet 15 Quinceanera Dresses Added to Magicquinceaneradresses.com’s Product Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... ... “Finding Christ Through Social Media: Year One #A365DayJourney to ... path toward true communion with God. “Finding Christ Through Social Media: Year One ... published author Lea Michelle Johnson, a follower of Christ, wife and mother who ...
(Date:3/24/2017)... ... , ... “The Adventures of Joey, The Dog Who Barks at Puddles”: a ... to the fullest, as God intended. “The Adventures of Joey, The Dog Who Barks ... pursuing her passion for writing, especially about truth and human behavior. , Published by ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... to their communities, 16 more public health departments have been awarded national accreditation ... another 4.5 million people into the expanding network of communities across the nation ...
(Date:3/23/2017)... ... 23, 2017 , ... The MBI “Hall of Fame” recognizes the contributions of those whose careers ... impact on the careers of all others involved. , On Monday, March 21st, ... MBI’s Hall of Fame. The induction took place during the World of Modular – ...
(Date:3/23/2017)... Atlanta, GA (PRWEB) , ... March 23, 2017 ... ... announced the release of SmartBen NOW, an innovative mobile app and centralized benefits ... gather and present critical information securely from multiple locations. For the first time, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 24, 2017 FinancialBuzz.com News Commentary   ... Medical cannabis products around the ... Inc., projects that the global medical cannabis market will reach a value ... is a major market for the new growing industry. By the end ... legally buy and sell medical cannabis. More conservative states like ...
(Date:3/24/2017)... 24, 2017 A ReportsnReports.com report says, over ... rapidly as the global sales of Adcetris and Kadcyla have been ... antibody drug conjugates market is driven by large number of ADC ... therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 Major Company ...
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Business Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , Latin America ... for the period 2015 through 2022. Also, a six-year historic analysis is ...
Breaking Medicine Technology: